Volume 95, Issue 5 pp. 311-314
Full Access

Cerebrospinal fluid proteins in subclinical and overt hypothyroidism

E. Nyström

Corresponding Author

E. Nyström

Departments of Endocrinology (The Thyroid Unit), Sahlgren's University Hospital, University of Goteborg, S-413 45 Göteborg, Sweden

Dr Nyström, Department of Endocrinology, Sahlgren's University Hospital, University of Göteborg, S-413 45 Göteborg, SwedenSearch for more papers by this author
A. Hamberger

A. Hamberger

Cell Biology, University of Goteborg, S-413 90 Göteborg, Sweden

Search for more papers by this author
G. Lindstedt

G. Lindstedt

Clinical Chemistry (The Thyroid Unit), Sahlgren's University Hospital, University of Goteborg, S-413 45 Göteborg, Sweden

Search for more papers by this author
C. Lundquist

C. Lundquist

Neurology, Sahlgren's University Hospital, University of Göteborg, S-413 45 Göteborg, Sweden

Search for more papers by this author
C. Wikkelsö

C. Wikkelsö

Neurology, Sahlgren's University Hospital, University of Göteborg, S-413 45 Göteborg, Sweden

Search for more papers by this author
First published: 29 January 2009
Citations: 18

Abstract

Patients and methods - We analysed cerebrospinal fluid (CSF) albumin and immunoglobulin0 G (IgG) concentrations and psychometric performance in subclinical (n=6) and overt hypothyroidism (n= 9) before and after 6 months with L-thyroxine. Results - In overt hypothyroidism, CSF albumin and IgG concentrations were increased before therapy [mean(SD): 328(156) mg/1 and 69(27) mg/1], but within the reference interval [198(48) mg/1 and 39(11) mg/1], P<0.05, after therapy. In contrast, in subclinical hypothyroidism CSF protein concentrations were within the reference intervals before and after therapy. Psychometric testing indicated an improvement in performance in both groups. Conclusion - The increase in CSF proteins in overt hypothyroidism does not appear to be related to thyroid autoimmune disease per se, since we found no increase in CSF proteins in individuals with subclinical hypothyroidism and presence of thyroid antibodies. The increase might rather be caused by a blood-brain barrier dysfunction related to low thyroid hormone concentrations.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.